Nsg 6005 final e - Study guides, Class notes & Summaries

NSG 6005 FINAL EXAM QUESTIONS AND ANSWERS 100% CORRECT Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - Answer- C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state is achieved. C. Bl...

NSG 6005 FINAL EXAM QUESTIONS AND ANSWERS 100% CORRECT Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - Answer- C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state is achieved. C. Bl...

NSG 6005 FINAL EXAM 2 LATEST 2024 WITH ALL 100 QUESTIONS AND CORRECT VERIFIED ANSWERS ALREADY GRADED A+| NSG 6005 ADVANCED PHARMACOLOGY FINAL EXAM 2 (BRAND NEW!!) Jamie is a thirty-four-year-old pregnant woman with familial hyperlipidemia and elevated LDL levels. What is the appropriate treatment for a pregnant woman? - ANSWER-Bile acid-binding resins An appropriate drug for the treatment of depression with anxiety would be - ANSWER-escitalopram (Lexapro) Dwayne was recently started o...

NSG 6005 FINAL EXAM | LATEST QUESTIONS AND ANSWERS LATEST2024/25

NSG 6005 FINAL EXAM 2024/2025 UPDATED QUESTIONS WITH 100% CORRECT ANSWERS Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - ANSWERS C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state...

NSG 6005 FINAL EXAM 2024/2025 UPDATED QUESTIONS WITH 100% CORRECT ANSWERS Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - ANSWERS C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state...

NSG 6005 FINAL Exam Verified 2024

NSG 6005 FINAL EXAM Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - CORRECT ANSWER -C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state is achieved. C. Blood glucose ...

NSG 6005 FINAL EXAM Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - CORRECT ANSWER -C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state is achieved. C. Blood glucose ...